Articles dans des revues avec comité de lecture (400)
  1. 8. Bosi, E., Marchetti, P., Rutter, G. A., & Eizirik, D. L. (2022). Human alpha cell transcriptomic signatures of types 1 and 2 diabetes highlight disease-specific dysfunction pathways. iScience, 25(10), 105056. doi:10.1016/j.isci.2022.105056
  2. 9. Giusti, L., Tesi, M., Ciregia, F., Marselli, L., Zallocco, L., Suleiman, M., De Luca, C., Del Guerra, S., Zuccarini, M., Trerotola, M., Eizirik, D. L., Cnop, M., Mazzoni, M. A., Marchetti, P., Lucacchini, A., & Ronci, M. (2022). The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved. Cells, 11(15), 2465. doi:10.3390/cells11152465
  3. 10. Suleiman, M., Marselli, L., Cnop, M., Eizirik, D. L., Luca, C. D., Femia, F. F., Tesi, M., Guerra, S. D., & Marchetti, P. (2022). The Role of Beta Cell Recovery in Type 2 Diabetes Remission. International journal of molecular sciences, 23(13), 7435. doi:10.3390/ijms23137435
  4. 11. Cantley, J., & Eizirik, D. L. (2022). 100 years of insulin: progress, current perspectives and future challenges. Journal of Endocrinology, 252(3), E1-E3. doi:10.1530/JOE-21-0391
  5. 12. Yang, C. H., Ann-Onda, D., Lin, X., Fynch, S., Nadarajah, S., Pappas, E. G., Liu, X., Scott, J., Oakhill, J. J., Galic, S., Shi, Y.-C., Moreno-Asso, A., Smith, C., Loudovaris, T., Levinger, I., Eizirik, D. L., Laybutt, R. D., Herzog, H., Thomas, H. H., & Loh, K. (2022). Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes. Molecular metabolism, 55, 101413. doi:10.1016/j.molmet.2021.101413
  6. 13. Wu, W., Syed, F., Simpson, E., Lee, C. C., Liu, J., Chang, G., Dong, C., Seitz, C., Eizirik, D. L., Mirmira, R. R., Liu, Y., & Evans-Molina, C. (2022). Impact of Proinflammatory Cytokines on Alternative Splicing Patterns in Human Islets. Diabetes (New York, N.Y.), 71(1), 116-127. doi:10.2337/db20-0847
  7. 14. Kalwat, M. M., Scheuner, D., Rodrigues-Dos-Santos, K., Eizirik, D. L., & Cobb, M. M. (2021). The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress. Endocrinology, 162(11). doi:10.1210/endocr/bqab173
  8. 15. Alonso, L., Piron, A., Morán, I., Guindo-Martínez, M., Bonàs-Guarch, S., Atla, G., Miguel-Escalada, I., Royo, R., Puiggròs, M., Garcia-Hurtado, X., Suleiman, M., Marselli, L., Esguerra, J. L. S., Turatsinze, J. V., Torres, J. M., Nylander, V., Chen, J., Eliasson, L., Defrance, M., Amela, R., MAGIC,, Mulder, H., Gloyn, A. L., Groop, L., Marchetti, P., Eizirik, D. L., Ferrer, J., Mercader, J. J., Cnop, M., & Torrents, D. (2021). TIGER: The gene expression regulatory variation landscape of human pancreatic islets. Cell reports, 37(2), 109807. doi:10.1016/j.celrep.2021.109807
  9. 16. Eizirik, D. L., Szymczak, F., De Oliveira Alvelos, M., & Martin, F. (2021). From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes. Diabetes, 70(9), 1915-1925. doi:10.2337/dbi20-0046
  10. 17. Eizirik, D. L., Szymczak, F., Alvelos, M. I., & Martin, F. (2021). From Pancreatic β -Cell Gene Networks to Novel Therapies for Type 1 Diabetes. Diabetes (New York, N.Y.), dbi200046. doi:10.2337/dbi20-0046
  11. 18. Alvelos, M. I., Szymczak, F., Castela, A., Marin Canas, S., Marmontel De Souza, B., Gkantounas, Y., Colli, M. L., Fantuzzi, F., Cosentino, C., Igoillo Esteve, M., Marselli, L., Marchetti, P., Cnop, M., & Eizirik, D. L. (2021). A functional genomic approach to identify referencegenes for human pancreatic beta cellreal-time quantitative RT-PCR analysis. Islets.
  12. 19. Bosi, E., Marselli, L., De Luca, C., Suleiman, M., Tesi, M., Ibberson, M., Eizirik, D. L., Cnop, M., & Marchetti, P. (2021). Integration of single-cell datasets reveals novel transcriptomic signatures of β-cells in human type 2 diabetes. NAR Genomics and Bioinformatics, 3(2), 1. doi:10.1093/nargab/lqaa097
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 Suivant >>